ERK5 is activated by oncogenic BRAF and promotes melanoma growth

Malignant melanoma is among the most aggressive cancers and its incidence is increasing worldwide. Targeted therapies and immunotherapy have improved the survival of patients with metastatic melanoma in the last few years; however, available treatments are still unsatisfactory. While the role of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tusa, Ignazia, Gagliardi, Sinforosa, Tubita, Alessandro, Pandolfi, Silvia, Urso, Carmelo, Borgognoni, Lorenzo, Wang, Jinhua, Deng, Xianming, Gray, Nathanael S, Stecca, Barbara, Rovida, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945581/
https://www.ncbi.nlm.nih.gov/pubmed/29483645
http://dx.doi.org/10.1038/s41388-018-0164-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945581/
https://www.ncbi.nlm.nih.gov/pubmed/29483645
http://dx.doi.org/10.1038/s41388-018-0164-9

Ejemplares similares